TD Cowen Maintains Market Perform on Amedisys, Raises Price Target to $101
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Gary Taylor maintains a Market Perform rating on Amedisys (NASDAQ:AMED) and raises the price target from $84 to $101.
July 31, 2023 | 7:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Gary Taylor maintains a Market Perform rating on Amedisys and raises the price target from $84 to $101.
The news of TD Cowen analyst maintaining a Market Perform rating on Amedisys and raising the price target from $84 to $101 is directly related to the company. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100